普米斯生物被收购,一家B轮公司卖了68亿

投资界
26 Nov 2024

一笔并购刷屏医药圈。近日,专注抗体新药研发的普米斯生物技术公司(简称“普米斯生物”)宣布与跨国药企BioNTech SE(简称“BioNTech”) 达成股权收购协议,交易总价最高可达9.5亿美元(约合人民币68.78亿元)。成立于2018年,普米斯生物堪称双抗领域的明星企业,身后集结一众投资机构,还曾谋划IPO。旗下重磅药物PM8002/BNT327,此前曾获得买家BioNTech青睐,达成授权...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10